GlassScriptPhysician profile
Kristina Grove
NPI 1558940676
$8,681.86
in general payments reported to CMS, 2019-2025
31 companies · $3,460 in 2025
The $3,460 reported for 2025 was more than what 98% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,397 · 2023: $1,754 · 2024: $2,070 · 2025: $3,460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,284.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,433.01 | 2022-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, General - Pain Management |
| Saluda Medical Americas, INC. | $1,542.13 | 2023-2025 | Evoke, Evoke Scs |
| Abbott Laboratories | $1,054.79 | 2022-2025 | Proclaim, Eterna, Axium |
| Nevro Corp. | $692.78 | 2022-2024 | Senza |
| Spinal Simplicity, LLC | $561.05 | 2025 | Ha Minuteman G3-R |
| Abbvie INC. | $473.70 | 2022-2025 | |
| Medtronic, INC. | $447.85 | 2022-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Spr Therapeutics, INC | $326.64 | 2023-2025 | Sprint Pns System |
| Nalu Medical, INC. | $263.00 | 2023-2025 | Nalu Neurostimulation System |
| Tersera Therapeutics LLC | $184.89 | 2022-2025 | Prialt |
| Protega Pharmaceutials INC | $97.03 | 2025 | Roxybond |
| Collegium Pharmaceutical, INC. | $69.40 | 2024-2025 | Belbuca, Xtampza |
| Averitas Pharma INC. | $63.22 | 2023 | Qutenza |
| Si-Bone, INC. | $55.35 | 2024-2025 | |
| Grt US Holding, INC. | $48.48 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $47.76 | 2023-2024 | Tirosint, Licart, Tirosint |
| Scilex Pharmaceuticals INC. | $42.95 | 2025 | |
| Painteq LLC | $42.53 | 2023-2024 | Painteq |
| Mml US, INC. | $24.72 | 2025 | Reactiv8 |
| Biohaven Pharmaceutical Holding Company LTD. | $24.21 | 2022 | |
| International Rehabilitative Sciences, INC | $23.02 | 2023 | Rs 4i Plus Sequential Stimulator |
| Tonix Medicines, INC. | $20.07 | 2025 | Tonmya |
| Vertex Pharmaceuticals Incorporated | $18.12 | 2024 | |
| Impel Pharmaceuticals INC. | $17.69 | 2022 | |
| Electronic Waveform Lab, INC. | $17.62 | 2025 | |
| Curonix LLC | $16.05 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Fidia Pharma USA INC. | $16.04 | 2025 | Hymovis, Triluron |
| Lundbeck LLC | $15.59 | 2025 | Vyepti |
| Baudax Bio INC. | $14.38 | 2022 | |
| Avanos Medical | $14.17 | 2025 | Trivisc Sodium Hyaluronate |
| Pfizer INC. | $13.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristina Grove listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.